Recent Quotes (30 days)

You have no recent quotes
chg | %

Hercules Capital Inc  

(Public, NYSE:HTGC)   Watch this stock  
Find more results for NASDAQ:HTGC
+0.13 (1.05%)
Sep 20 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 12.43 - 12.64
52 week 11.64 - 15.68
Open 12.43
Vol / Avg. 0.00/474,520.00
Mkt cap 1.04B
P/E 13.60
Div/yield 0.31/9.90
EPS 0.92
Shares 82.80M
Beta 0.83
Inst. own 46%
Nov 1, 2017
Q3 2017 Hercules Capital Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Aug 3, 2017
Q2 2017 Hercules Capital Inc Earnings Call - Webcast
Aug 3, 2017
Q2 2017 Hercules Capital Inc Earnings Release
Jul 7, 2017
Hercules Capital Inc Annual Shareholders Meeting (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 68.42% 39.25%
Operating margin 52.17% 52.75%
EBITD margin - 55.62%
Return on average assets 8.38% 4.93%
Return on average equity 16.26% 8.96%
Employees 64 -
CDP Score - -


400 Hamilton Ave Ste 310
PALO ALTO, CA 94301-1805
United States - Map
+1-650-2893060 (Phone)
+1-650-4739194 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Hercules Capital, Inc. is a specialty finance company. The Company is an internally managed, non-diversified, closed-end investment company. The Company focuses on providing senior secured venture growth loans to venture capital-backed companies in a range of technology, life sciences, and sustainable and renewable technology industries. The Company's investment objective is to maximize its portfolio total return by generating current income from its debt investments and capital appreciation from its warrant and equity-related investments. The Company's primary business objectives are to increase its net income, net operating income and net asset value (NAV) by investing in structured debt with warrants and equity of venture capital-backed companies in technology-related industries with attractive current yields and the potential for equity appreciation and realized gains. The Company focuses its investments in companies active in the technology industry sub-sectors.

Officers and directors

Manuel A. Henriquez Chairman of the Board, President, Chief Executive Officer
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark Robert Harris CPA Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Scott Bluestein Chief Investment Officer
Age: 38
Bio & Compensation  - Reuters
Melanie Grace Chief Compliance Officer, General Counsel, Secretary
Age: 48
Bio & Compensation  - Reuters
Gerald R. Waldt Jr. Controller
Bio & Compensation  - Reuters
Allyn C. Woodward Jr. Lead Independent Director
Age: 76
Bio & Compensation  - Reuters
Robert P. Badavas Independent Director
Age: 64
Bio & Compensation  - Reuters
Thomas J. Fallon Independent Director
Age: 55
Bio & Compensation  - Reuters
Joseph F. Hoffman Independent Director
Age: 68
Bio & Compensation  - Reuters
Susanne D. Lyons Independent Director
Age: 60
Bio & Compensation  - Reuters